| Active substance |
Brimonidine |
| Also known as |
Brimonidine tartrate |
| Blood pressure |
May lower blood pressure |
| Chemical name |
5-Bromo-6-(2-imidazolidinylideneamino)quinoxaline L-tartrate |
| Dosage (medical) |
Typically 0.1% or 0.15% solution, one drop in the affected eye(s) three times a day |
| Dosage (sports) |
Not applicable |
| Effects |
Decreases intraocular pressure by reducing aqueous humor synthesis and increasing uveoscleral outflow |
| Formula |
C11H10BrN5В·C4H6O6 |
| Half-life |
Approximately 3 hours |
| Hepatotoxicity |
No known hepatotoxicity |
| Lab Test |
Not typically required |
| Main action |
Reduces intraocular pressure |
| Side effects |
Eye redness, itching, watering, eyelid swelling, dizziness, dry mouth, and taste disturbances |
| Storage conditions |
Store at 15-25В°C (59-77В°F), away from light and moisture |
| Substance class |
Alpha agonist |
| Trade name |
Alphagan, Alphagan P |
| Use in sports |
Not typically used in sports |
| Water Retention |
None |
| Manufacturer |
Allergan Pvt. Ltd. |
| Packing |
1 bottle/pack |
